# Aldeyra Therapeutics, Inc.: filings

ALDX · Nasdaq · CIK 1341235 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/aldx.md) · [Financials](/companies/aldx/financials.md) · [Filings](/companies/aldx/filings.md) · [Insiders](/companies/aldx/insiders.md)

## Reports and events: 252 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 190, 8-K 176, 10-Q 38, SC 13G/A 30, 3 23, SC 13G 16, 424B5 15, S-8 15, CORRESP 14, 10-K 12, DEF 14A 12, DEFA14A 11, EFFECT 10, UPLOAD 8, 144 7, S-1/A 7, 4/A 6, POS AM 6, SCHEDULE 13G/A 6, ARS 4, D 4, S-1 4, S-3 4, FWP 3, 10-K/A 2, 424B1 2, 424B4 2, CT ORDER 2, 8-A12B 1, 8-A12B/A 1, 8-K/A 1, CERTNAS 1, DRS 1, DRS/A 1, S-8 POS 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-29 | 03:01 ET | [8-K](/filings/0001193125-26-405954.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-405954 |
| 2026-08-06 | 16:02 ET | [10-Q](/filings/0001341235-26-000010.md) | Quarterly report, period 2026-06-30 | 0001341235-26-000010 |
| 2026-07-30 | 17:07 ET | [8-K](/filings/0001193125-26-326337.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-326337 |
| 2026-07-15 | 16:46 ET | [8-K](/filings/0001193125-26-304880.md) | 8.01 Other events | 0001193125-26-304880 |
| 2026-06-10 | 20:30 ET | [8-K](/filings/0001193125-26-264514.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-264514 |
| 2026-05-07 | 16:02 ET | [10-Q](/filings/0001341235-26-000006.md) | Quarterly report, period 2026-03-31 | 0001341235-26-000006 |
| 2026-05-01 | 08:00 ET | [8-K](/filings/0001193125-26-199157.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-199157 |
| 2026-04-27 | 16:10 ET | [DEF 14A](/filings/0001193125-26-182099.md) | Proxy statement, period 2025-06-10 | 0001193125-26-182099 |
| 2026-04-20 | 17:00 ET | [8-K](/filings/0001193125-26-164198.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-164198 |
| 2026-04-01 | 16:25 ET | [8-K](/filings/0001193125-26-137984.md) | 8.01 Other events | 0001193125-26-137984 |
| 2026-03-17 | 08:39 ET | [8-K](/filings/0001193125-26-109511.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-109511 |
| 2026-02-27 | 16:47 ET | [10-K](/filings/0001193125-26-083012.md) | Annual report, period 2025-12-31 | 0001193125-26-083012 |
| 2025-12-31 | 17:07 ET | [8-K](/filings/0001193125-25-338394.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-338394 |
| 2025-12-16 | 19:49 ET | [8-K](/filings/0001193125-25-319638.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-319638 |
| 2025-11-13 | 07:00 ET | [8-K](/filings/0001193125-25-278804.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-278804 |
| 2025-11-05 | 16:16 ET | [10-Q](/filings/0001193125-25-266989.md) | Quarterly report, period 2025-09-30 | 0001193125-25-266989 |
| 2025-10-28 | 07:00 ET | [8-K](/filings/0001193125-25-252200.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-252200 |
| 2025-08-19 | 07:00 ET | [8-K](/filings/0000950170-25-109932.md) | 9.01 Financial statements and exhibits | 0000950170-25-109932 |
| 2025-08-07 | 16:03 ET | [10-Q](/filings/0000950170-25-104971.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104971 |
| 2025-07-17 | 07:01 ET | [8-K](/filings/0001213900-25-064869.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-064869 |
| 2025-06-26 | 07:01 ET | [8-K](/filings/0001213900-25-058035.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-058035 |
| 2025-06-17 | 07:03 ET | [8-K](/filings/0001213900-25-054949.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-054949 |
| 2025-06-11 | 16:01 ET | [8-K](/filings/0000950170-25-084820.md) | 5.07 Shareholder vote results | 0000950170-25-084820 |
| 2025-05-14 | 17:13 ET | [10-Q](/filings/0000950170-25-071602.md) | Quarterly report, period 2025-03-31 | 0000950170-25-071602 |
| 2025-05-06 | 07:01 ET | [8-K](/filings/0001193125-25-113275.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-113275 |
| 2025-04-25 | 16:19 ET | [DEF 14A](/filings/0001193125-25-096899.md) | Proxy statement, period 2025-06-10 | 0001193125-25-096899 |
| 2025-04-17 | 16:01 ET | [8-K](/filings/0001213900-25-032947.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-032947 |
| 2025-04-03 | 16:50 ET | [8-K](/filings/0001193125-25-072424.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-072424 |
| 2025-03-28 | 17:19 ET | [10-K/A](/filings/0000950170-25-046946.md) | Annual report, amended, period 2024-12-31 | 0000950170-25-046946 |
| 2025-02-28 | 16:36 ET | [10-K](/filings/0000950170-25-030102.md) | Annual report, period 2024-12-31 | 0000950170-25-030102 |
| 2024-11-18 | 07:01 ET | [8-K](/filings/0001213900-24-099333.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-099333 |
| 2024-11-07 | 16:02 ET | [10-Q](/filings/0000950170-24-123248.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123248 |
| 2024-10-03 | 07:01 ET | [8-K](/filings/0001213900-24-084844.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-084844 |
| 2024-10-02 | 16:10 ET | [8-K](/filings/0001193125-24-231158.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-231158 |
| 2024-09-03 | 09:02 ET | [8-K](/filings/0001193125-24-211645.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-211645 |
| 2024-08-08 | 07:06 ET | [8-K](/filings/0001213900-24-066327.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-066327 |
| 2024-08-01 | 16:11 ET | [8-K](/filings/0001193125-24-191518.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-191518 |
| 2024-08-01 | 16:03 ET | [10-Q](/filings/0000950170-24-089238.md) | Quarterly report, period 2024-06-30 | 0000950170-24-089238 |
| 2024-06-20 | 07:01 ET | [8-K](/filings/0001213900-24-054003.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-054003 |
| 2024-06-13 | 07:01 ET | [8-K](/filings/0001213900-24-052234.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-052234 |
| 2024-06-07 | 16:07 ET | [8-K](/filings/0001193125-24-157328.md) | 5.07 Shareholder vote results | 0001193125-24-157328 |
| 2024-05-02 | 16:03 ET | [10-Q](/filings/0000950170-24-052056.md) | Quarterly report, period 2024-03-31 | 0000950170-24-052056 |
| 2024-04-25 | 07:01 ET | [8-K](/filings/0001213900-24-035953.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-035953 |
| 2024-04-22 | 16:11 ET | [DEF 14A](/filings/0001193125-24-104862.md) | Proxy statement, period 2024-06-04 | 0001193125-24-104862 |
| 2024-03-28 | 07:01 ET | [8-K](/filings/0001213900-24-026871.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-026871 |
| 2024-03-07 | 16:06 ET | [10-K](/filings/0000950170-24-027933.md) | Annual report, period 2023-12-31 | 0000950170-24-027933 |
| 2024-02-13 | 16:00 ET | [8-K](/filings/0001157523-24-000230.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001157523-24-000230 |
| 2024-01-04 | 07:00 ET | [8-K](/filings/0001157523-24-000014.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001157523-24-000014 |
| 2023-12-21 | 16:06 ET | [8-K](/filings/0001193125-23-301185.md) | 8.01 Other events | 0001193125-23-301185 |
| 2023-12-19 | 07:05 ET | [8-K](/filings/0001157523-23-001841.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001157523-23-001841 |

Page 1 of 6. [Older](/companies/aldx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.